Spring 2024

Read the full issue

A letter from our Editor-in-Chief

It’s a pleasure to introduce you to the inaugural issue of Hypothesis – a new magazine providing perspectives, insights, and thought leadership in the life sciences. With three issues a year, Hypothesis strives to be the go-to publication for Canadian life sciences professionals. Hypothesis will bring you up to date on industry news, follow people on the move, and share conversations with inspirational voices. Most importantly, we’ll help you better understand the health care environment around you, and the issues that impact the success of Canadian life sciences companies and brands.

Every issue will include the voice of a physician, who will provide a wide-ranging perspective on all things medicine and disease management. We’ll also always feature an interview with a patient, to remind you of your ‘why’ and help you understand more about your patients’ journeys to diagnosis and therapy.

Another recurring feature of Hypothesis will be important conversations with key thought leaders about shifts in how we’re thinking about health care. In this inaugural issue, we talk to Drew Taylor, CEO of Acorn Labs, a regenerative medicine company, about where he sees longevity medicine going, and what the evidence says about how we can live better, longer lives. In future issues, we’ll be speaking to thought leaders in Health Investment Banking, AI, obesity research, and more.

With an ever-growing footprint of pharmaceutical and biotech operations in Canada, Canada’s life sciences industry is coming into its own. We hope you enjoy this issue and that you’ll share it with your peers. We welcome your feedback and look forward to hearing from you about how we can continue to provide relevant and timely information!

Welcome aboard!

Lea

Read the full issue

Inside this Issue

  • You Have to Start Somewhere

    Biden’s Health Care Policy Changes Will Be Remembered for Decades to Come

    Say what you will about the economy. And his foreign policy. And his age. And all the rest of his baggage. But whether Joe Biden is re-elected or not, his healthcare policy changes will be remembered for decades to come. Yes, there are still humongous challenges, like the expunging of millions of Medicaid (i.e. low…

  • Healing Thyself: The Future of Regenerative Medicine

    A Conversation With Drew Taylor, CEO of Acorn Labs

    Dr. Drew Taylor is a pioneer in the field of regenerative medicine. Convinced about the potential for regenerative medicine to prevent disease and slow aging, he launched a company that banks people’s stem cells, ensuring they’ll have access to higher quality cells for future regenerative applications. Taylor spoke with the president of Catalytic Health and…

  • Incorporate Values into Brand Strategy

    Historically, organizational reputation is linked to company values—and these values are linked to financial performance

    We hope you will find our advice both timely and useful. For this, the inaugural issue, we provide you with a summary of our latest research about values, brand portfolio strategy, and reputation recently published in the International Journal of Pharmaceutical and Healthcare Marketing. We also highlight the recommendations we made for improving brand reputation…

  • Charting New Waters

    A Q&A with Dr. Remo Panaccione, Director of the Inflammatory Bowel Disease Unit at the University of Calgary

    From Physician Shortages to Online Medical Misinformation to AI: How Medicine Can Navigate Complex Challenges

  • The Long and Winding Road

    A Conversation with Dr. Soania Mathur, Patient and Parkinson’s Advocate

    Dr. Soania Mathur is a patient and a physician. She was diagnosed with young-onset Parkinson disease at age 28. She continued her family practice, while growing her family, for 12 more years, before the burden of living with the disease required her to resign clinical practice. She now focuses her time on Parkinson’s disease advocacy.…

  • Move Fast and Fix Things

    The Rewards and Challenges of Leading a Small Biotech Firm in a Time of Great Uncertainty

    Thinking about a future in management? Anand Janack, General Manager of BioCryst Canada, spoke to Hypothesis publisher Rohit Khanna about his career path, the advantages and challenges of working within a smaller pharmaceutical organization, and his advice for those who want to follow in his footsteps. As a leader of a company focused on rare…